MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):293-298. doi: 10.15585/mmwr.mm7108a3.
Isolation is recommended during acute infection with SARS-CoV-2, the virus that causes COVID-19, but the duration of infectiousness varies among individual persons. Rapid antigen test results have been correlated with detection of viable virus (1-3) and might inform isolation guidance, but data are limited for the recently emerged SARS-CoV-2 B.1.1.529 (Omicron) variant. On January 5, 2022, the Yukon-Kuskokwim Health Corporation (YKHC) recommended that persons with SARS-CoV-2 infection isolate for 10 days after symptom onset (or, for asymptomatic persons, 10 days after a positive nucleic acid amplification or antigen test result). However, isolation could end after 5-9 days if symptoms were resolving or absent, fever was absent for ≥24 hours without fever-reducing medications, and an Abbott BinaxNOW COVID-19 Ag (BinaxNOW) rapid antigen test result was negative. Antigen test results and associated individual characteristics were analyzed among 3,502 infections reported to YKHC during January 1-February 9, 2022. After 5-9 days, 396 of 729 persons evaluated (54.3%) had a positive antigen test result, with a declining percentage positive over time. In a multivariable model, a positive antigen test result was more likely after 5 days compared with 9 days (adjusted odds ratio [aOR] = 6.39) or after symptomatic infection (aOR = 9.63), and less likely after previous infection (aOR = 0.30), receipt of a primary COVID-19 vaccination series (aOR = 0.60), or after both previous infection and receipt of a primary COVID-19 vaccination series (aOR = 0.17). Antigen tests might be a useful tool to guide recommendations for isolation after SARS-CoV-2 infection. During the 10 days after infection, persons might be infectious to others and are recommended to wear a well-fitting mask when around others, even if ending isolation after 5 days.
在感染导致 COVID-19 的 SARS-CoV-2 病毒期间建议进行隔离,但个体之间的传染性持续时间不同。快速抗原检测结果与检测活病毒相关(1-3),并可能为隔离指南提供信息,但对于最近出现的 SARS-CoV-2 B.1.1.529(Omicron)变体,数据有限。2022 年 1 月 5 日,育空-科尤库克卫生公司(YKHC)建议 SARS-CoV-2 感染者在出现症状后隔离 10 天(或无症状感染者在核酸扩增或抗原检测结果呈阳性后隔离 10 天)。然而,如果症状正在缓解或消失,且无发热,且未使用退热药物的情况下持续 24 小时以上无发热,以及 Abbott BinaxNOW COVID-19 Ag(BinaxNOW)快速抗原检测结果为阴性,那么隔离可以在 5-9 天后结束。2022 年 1 月 1 日至 2 月 9 日期间,YKHC 报告了 3502 例感染病例,分析了这些病例的抗原检测结果和相关个体特征。在 5-9 天后,在 729 名接受评估的患者中,有 396 人(54.3%)抗原检测结果呈阳性,且随着时间的推移,阳性百分比逐渐降低。在多变量模型中,与 9 天相比,5 天后抗原检测结果呈阳性的可能性更大(调整后的优势比[aOR] = 6.39),或与症状性感染相比(aOR = 9.63),与既往感染相比(aOR = 0.30),与接种完新冠病毒初级疫苗系列(aOR = 0.60),或与既往感染和接种完新冠病毒初级疫苗系列(aOR = 0.17)相比,可能性更低。抗原检测可能是指导 SARS-CoV-2 感染后隔离建议的有用工具。在感染后的 10 天内,感染者可能会传染给他人,建议在与他人接触时佩戴贴合良好的口罩,即使在 5 天后结束隔离。